nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—OPRD1—forebrain—attention deficit hyperactivity disorder	0.0419	0.116	CbGeAlD
Hydrocodone—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0402	0.111	CbGeAlD
Hydrocodone—OPRM1—forebrain—attention deficit hyperactivity disorder	0.0286	0.0793	CbGeAlD
Hydrocodone—Galantamine—CHRNA4—attention deficit hyperactivity disorder	0.0243	0.47	CrCbGaD
Hydrocodone—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0228	0.0631	CbGeAlD
Hydrocodone—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.0219	0.0607	CbGeAlD
Hydrocodone—OPRK1—nervous system—attention deficit hyperactivity disorder	0.0218	0.0605	CbGeAlD
Hydrocodone—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.021	0.0582	CbGeAlD
Hydrocodone—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.0205	0.0569	CbGeAlD
Hydrocodone—OPRM1—midbrain—attention deficit hyperactivity disorder	0.0189	0.0523	CbGeAlD
Hydrocodone—Dextromethorphan—CHRNA4—attention deficit hyperactivity disorder	0.0182	0.352	CrCbGaD
Hydrocodone—OPRD1—brain—attention deficit hyperactivity disorder	0.0174	0.0482	CbGeAlD
Hydrocodone—OPRK1—brain—attention deficit hyperactivity disorder	0.0167	0.0462	CbGeAlD
Hydrocodone—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0155	0.043	CbGeAlD
Hydrocodone—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.0149	0.0414	CbGeAlD
Hydrocodone—OPRM1—brain—attention deficit hyperactivity disorder	0.0119	0.0329	CbGeAlD
Hydrocodone—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0115	0.0318	CbGeAlD
Hydrocodone—Dextromethorphan—SLC6A4—attention deficit hyperactivity disorder	0.00921	0.178	CrCbGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00683	0.0116	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00679	0.0115	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00659	0.0112	CbGpPWpGaD
Hydrocodone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00632	0.0175	CbGeAlD
Hydrocodone—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00622	0.0172	CbGeAlD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00612	0.0104	CbGpPWpGaD
Hydrocodone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00609	0.0169	CbGeAlD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00599	0.0102	CbGpPWpGaD
Hydrocodone—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00599	0.0166	CbGeAlD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00598	0.0102	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00595	0.0101	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00585	0.00996	CbGpPWpGaD
Hydrocodone—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00585	0.0162	CbGeAlD
Hydrocodone—OPRM1—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00557	0.00948	CbGpPWpGaD
Hydrocodone—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00545	0.00928	CbGpPWpGaD
Hydrocodone—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00526	0.00895	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00524	0.00892	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00517	0.0088	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00513	0.00874	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.0051	0.00869	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00506	0.00862	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00503	0.00856	CbGpPWpGaD
Hydrocodone—CYP2D6—brain—attention deficit hyperactivity disorder	0.00476	0.0132	CbGeAlD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00474	0.00806	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00455	0.00775	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00448	0.00762	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00446	0.00759	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00446	0.00759	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00443	0.00754	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00434	0.00738	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00415	0.00707	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00414	0.00705	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00406	0.00691	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00402	0.00684	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00399	0.00679	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00395	0.00672	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00391	0.00666	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00391	0.00665	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.0039	0.00664	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00385	0.00655	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00383	0.00653	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00378	0.00644	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00373	0.00634	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00366	0.00624	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00363	0.00618	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00363	0.00618	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00362	0.00616	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00356	0.00606	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00355	0.00604	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00352	0.00599	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00351	0.00597	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00348	0.00593	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00346	0.00589	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00342	0.00582	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00338	0.00574	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00337	0.00574	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00337	0.00574	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00336	0.00572	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00331	0.00563	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0033	0.00562	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0033	0.00561	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00327	0.00556	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00321	0.00547	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00319	0.00544	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00319	0.00542	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00317	0.0054	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00314	0.00534	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00311	0.00529	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0031	0.00528	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00309	0.00526	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00307	0.00522	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00305	0.0052	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00301	0.00512	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00298	0.00507	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00296	0.00503	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00293	0.00498	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00289	0.00492	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00289	0.00492	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00289	0.00492	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00285	0.00485	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00284	0.00484	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0028	0.00477	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00276	0.0047	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00275	0.00468	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00272	0.00463	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00272	0.00462	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00271	0.00461	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0027	0.0046	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00269	0.00458	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00268	0.00456	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00263	0.00447	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00258	0.00439	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00257	0.00438	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00253	0.00431	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00252	0.00429	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00251	0.00427	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0025	0.00425	CbGpPWpGaD
Hydrocodone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00247	0.00421	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00244	0.00416	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00243	0.00414	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00239	0.00407	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00237	0.00403	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00237	0.00403	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00236	0.00402	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00236	0.00402	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00234	0.00397	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00233	0.00396	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0023	0.00391	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00229	0.0039	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00229	0.00389	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00226	0.00384	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00221	0.00376	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0022	0.00375	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0022	0.00374	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00214	0.00364	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00213	0.00363	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0021	0.00357	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00207	0.00352	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00207	0.00352	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00206	0.0035	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00205	0.00349	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00202	0.00344	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00201	0.00341	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.002	0.00341	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00193	0.00328	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00191	0.00324	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00187	0.00318	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00186	0.00317	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0018	0.00307	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0018	0.00307	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00177	0.00302	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00177	0.00302	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00175	0.00298	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00175	0.00298	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00175	0.00297	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00173	0.00295	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0017	0.00289	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00163	0.00277	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00162	0.00275	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00161	0.00273	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00159	0.0027	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00154	0.00262	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00153	0.00261	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00153	0.0026	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00152	0.00259	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0015	0.00255	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00142	0.00242	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00141	0.0024	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00139	0.00237	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00139	0.00236	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00235	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00137	0.00234	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00135	0.0023	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00135	0.0023	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00135	0.0023	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00134	0.00228	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00133	0.00227	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00133	0.00226	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00132	0.00225	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00131	0.00223	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0013	0.00222	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00129	0.0022	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00129	0.00219	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00125	0.00212	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00124	0.00212	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00124	0.00212	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00209	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00122	0.00207	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00121	0.00206	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00121	0.00206	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00121	0.00205	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00119	0.00203	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00119	0.00202	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00118	0.00202	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00118	0.002	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00117	0.00199	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00116	0.00198	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00114	0.00194	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00113	0.00193	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00113	0.00192	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00113	0.00192	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00109	0.00186	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00109	0.00185	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00183	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00106	0.00181	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00105	0.00179	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00103	0.00175	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00102	0.00174	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00102	0.00173	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.001	0.0017	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.001	0.0017	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00099	0.00168	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000989	0.00168	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000982	0.00167	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000955	0.00163	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000937	0.00159	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000925	0.00157	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000921	0.00157	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000909	0.00155	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000898	0.00153	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000871	0.00148	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000864	0.00147	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000858	0.00146	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000852	0.00145	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000837	0.00142	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000822	0.0014	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000819	0.00139	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000791	0.00135	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000763	0.0013	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000761	0.0013	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000737	0.00125	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000725	0.00123	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000718	0.00122	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000716	0.00122	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000694	0.00118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000693	0.00118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000668	0.00114	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000667	0.00113	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000647	0.0011	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000645	0.0011	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000636	0.00108	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000628	0.00107	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000607	0.00103	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000586	0.000997	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000585	0.000995	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000564	0.00096	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000546	0.00093	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000541	0.00092	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000537	0.000914	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00053	0.000903	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000494	0.000841	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000467	0.000795	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00041	0.000697	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000373	0.000635	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000373	0.000635	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000367	0.000625	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000353	0.000601	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000346	0.000589	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000341	0.000581	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000298	0.000508	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000284	0.000483	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000247	0.000421	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000244	0.000415	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000244	0.000415	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00024	0.000408	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000226	0.000385	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000224	0.000382	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000223	0.00038	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000217	0.000369	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000195	0.000332	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000186	0.000316	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000183	0.000312	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000148	0.000252	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000147	0.00025	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	9.69e-05	0.000165	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.34e-05	0.000108	CbGpPWpGaD
